Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | CES2 | O00748 | 5/20 | 0.36 |
| ▸ | MAOA | P21397 | 3/20 | 0.34 |
| ▸ | MAOB | P27338 | 3/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.32 |
| ▸ | TNF | P01375 | 2/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15571625 | 0.91 | AKR1C3 (0.37) | PTGS2MAOAMAOBAKR1C3AKR1C2 | |
| SCHEMBL8506321 | 0.89 | PTGS2 (0.38) | PTGS2MAOAMAOBAKR1C3AKR1C2 | |
| SCHEMBL2221809 | 0.89 | AKR1C3 (0.37) | PTGS2MAOAMAOBAKR1C3AKR1C2 | |
| SCHEMBL2223120 | 0.89 | PTGS2 (0.38) | PTGS2MAOAMAOBAKR1C3AKR1C2 | |
| SCHEMBL15572432 | 0.88 | PTGS2 (0.34) | PTGS2AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL15570465 | 0.87 | AKR1C3 (0.39) | CES2MAOBAKR1C3 | |
| SCHEMBL8796929 | 0.87 | MAOA (0.34) | PTGS2MAOAMAOBAKR1C3 | |
| SCHEMBL2223831 | 0.83 | PTGS2 (0.32) | PTGS2AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL8428502 | 0.73 | PTGS2 (0.38) | PTGS2CES2MAOAMAOBAKR1C3 | |
| SCHEMBL8521003 | 0.72 | PTGS2 (0.45) | PTGS2AKR1C3AKR1C2AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2882426-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2015-06-17 | — | — | EP | disclosed |
| WO-2014026959-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2014-02-20 | — | — | WO | disclosed |